查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370358

口蹄疫 (FMD) 疫苗市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Foot and Mouth Disease (FMD) Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

概要

2023-2028 年市場概況：

2022 年，全球口蹄疫 (FMD) 疫苗市場規模達到 19.786 億美元。展望未來，IMARC 集團預計到 2028 年，市場規模將達到 30.707 億美元，2023 年年複合成長率 (CAGR) 為 7.2%。2028 年。

口蹄疫 (FMD) 是由感染偶蹄類動物的跨界傳染性病毒引起的。它主要影響牛，如水牛、豬、綿羊、山羊等，以及少數野生動物物種，包括鹿、野牛、駱駝、羚羊等。FMD 病毒 (FMDV) 有 7 種免疫學不同的血清型，即 O、A 、C、SAT1、SAT2、SAT3 和亞洲1. 這種病毒性疾病在動物中表現出常見症狀，如嘴唇和舌頭起水泡、發燒、流涎過多、厭食、肉和奶產量低等。氫氧化鋁、皂苷和油製劑，用於對抗口蹄疫收縮。

口蹄疫的高流行及其對動物產品國際貿易的社會經濟影響正在推動口蹄疫疫苗市場的發展。肉類加工業的發展和乳製品消費的增加也刺激了口蹄疫疫苗的需求。此外，對牲畜優質無病肉類供應的需求不斷成長，進一步促進了市場成長。除此之外，有關養牛的強制性規範的實施導致大量購買疫苗來控制口蹄疫疫情。此外，全球各地的政府機構還推出了多項提高意識計劃，以保護野牛和羚羊等瀕危野生動物物種免受口蹄疫的侵害。全球化的不斷發展以及已開發和發展中市場牲畜數量的不斷成長也推動了口蹄疫疫苗市場的發展。此外，為牲畜提供安全醫療保健實踐的獸醫中心的不斷增加也對市場成長產生了積極影響。

本報告回答的關鍵問題：

  • 迄今為止，全球口蹄疫（FMD）疫苗市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球口蹄疫 (FMD) 疫苗市場有何影響？
  • 主要區域市場有哪些？
  • 根據動物類型分類的市場是怎麼樣的？
  • 根據疫苗類型，市場的詳細情形如何？
  • 基於配銷通路的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球口蹄疫（FMD）疫苗市場的結構如何？誰是主要參與者？
  • 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球口蹄疫 (FMD) 疫苗市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按動物類型分類的市場細分

  • 牛
    • 市場走向
    • 市場預測
  • 豬
    • 市場走向
    • 市場預測
  • 綿羊和山羊
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：按疫苗類型分類的市場區隔

  • 常規疫苗
    • 市場走向
    • 油性疫苗
      • 市場走向
      • 市場預測
    • 氫氧化鋁/皂苷類疫苗
      • 市場走向
      • 市場預測
    • 市場預測
  • 緊急疫苗
    • 市場走向
    • 市場預測

第 8 章：按配銷通路分類的市場區隔

  • 政府機構
    • 市場走向
    • 市場預測
  • 經銷商/藥房
    • 市場走向
    • 市場預測
  • 私人獸醫
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場區隔

  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 孟加拉
      • 市場走向
      • 市場預測
    • 越南
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 阿根廷
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 奈及利亞
      • 市場走向
      • 市場預測
    • 衣索比亞
      • 市場走向
      • 市場預測
    • 伊朗
      • 市場走向
      • 市場預測
    • 阿爾及利亞
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 土耳其
      • 市場走向
      • 市場預測
    • 喬治亞州
      • 市場走向
      • 市場預測
    • 亞美尼亞
      • 市場走向
      • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特的五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Paramount Agrovet Pvt. Ltd.
    • Bayer AG
    • Biogenesis Bago
    • Boehringer Ingelheim International GmbH
    • Brilliant Bio Pharma Private Limited
    • China Animal Husbandry Group
    • FGBI "Federal Center for Animal Health"
    • Indian Immunologicals Ltd.
    • Limor de Colombia
    • Merck & Co. Inc
    • Vecol SA
    • Vetal Animal Health Products Inc.
Product Code: SR112023A2871

Abstract

Market Overview 2023-2028:

The global foot and mouth disease (FMD) vaccine market size reached US$ 1,978.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 3,070.7 Million by 2028, exhibiting a growth rate (CAGR) of 7.2% during 2023-2028.

The foot and mouth disease (FMD) occurs due to a transboundary, contagious virus that infects cloven-hoofed animals. It primarily affects cattle, such as buffaloes, pigs, sheep, goats, etc., and a few wildlife species, including deer, bison, camelid, antelope, etc. The FMD virus (FMDV) has seven immunologically distinct serotypes, namely O, A, C, SAT1, SAT2, SAT3, and Asia 1. This viral disease exhibits common symptoms in animals, such as blisters on lips and tongue, fever, excessive salivation, anorexia, low meat and milk productivity, etc. Several vaccines, based on aluminum hydroxide, saponin, and oil formulations, are used against FMD contraction.

The high prevalence of FMD along with its socio-economic impact on the international trade of animal products is driving the FMD vaccine market. The growing meat processing industry and the increasing consumption of dairy products are also fueling the need for FMD vaccines. Additionally, the rising demand for high-grade and disease-free meat supply from livestock is further augmenting the market growth. Apart from this, the implementation of mandatory norms regarding cattle rearing is leading to the bulk purchase of vaccines to control FMD outbreaks. Furthermore, government bodies across the globe are also introducing several awareness programs for protecting endangered wildlife species, such as bison and antelope, against FMD. Rising globalization along with the growing livestock population across both developed and developing markets is also driving the market for FMD vaccines. Furthermore, the increasing presence of veterinary centers providing safe healthcare practices for livestock is also creating a positive impact on the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global foot and mouth disease (FMD) vaccine market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on animal type, vaccine type and distribution channel.

Breakup by Animal Type:

Cattle

Pig

Sheep and Goat

Others

Breakup by Vaccine Type:

Conventional Vaccines

Oil-Based Vaccines

Aluminum hydroxide/saponin-based Vaccines

Emergency Vaccines

Breakup by Distribution Channel:

Government Organizations

Distributors/Pharmacies

Private Vet

Others

Breakup by Region:

Asia Pacific

China

India

Bangladesh

Vietnam

Korea

Others

Latin America

Brazil

Argentina

Others

Middle East and Africa

Nigeria

Ethiopia

Iran

Algeria

Others

Europe

Turkey

Georgia

Armenia

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Paramount Agrovet Pvt. Ltd., Bayer AG, Biogenesis Bago, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, China Animal Husbandry Group, FGBI "Federal Center for Animal Health", Indian Immunologicals Ltd., Limor De Colombia, Merck & Co., Inc., Vecol S.A and Vetal Animal Health Products Inc.

Key Questions Answered in This Report:

  • How has the global foot and mouth disease (FMD) vaccine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global foot and mouth disease (FMD) vaccine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the animal type?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global foot and mouth disease (FMD) vaccine market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Foot and Mouth Disease (FMD) Vaccine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Animal Type

  • 6.1 Cattle
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Pig
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Sheep and Goat
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Vaccine Type

  • 7.1 Conventional Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Oil-Based Vaccines
      • 7.1.2.1 Market Trends
      • 7.1.2.2 Market Forecast
    • 7.1.3 Aluminum hydroxide/saponin-based Vaccines
      • 7.1.3.1 Market Trends
      • 7.1.3.2 Market Forecast
    • 7.1.4 Market Forecast
  • 7.2 Emergency Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Government Organizations
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Distributors/Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Private Vet
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 Asia Pacific
    • 9.1.1 China
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 India
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
    • 9.1.3 Bangladesh
      • 9.1.3.1 Market Trends
      • 9.1.3.2 Market Forecast
    • 9.1.4 Vietnam
      • 9.1.4.1 Market Trends
      • 9.1.4.2 Market Forecast
    • 9.1.5 Korea
      • 9.1.5.1 Market Trends
      • 9.1.5.2 Market Forecast
    • 9.1.6 Others
      • 9.1.6.1 Market Trends
      • 9.1.6.2 Market Forecast
  • 9.2 Latin America
    • 9.2.1 Brazil
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Argentina
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 Others
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
  • 9.3 Middle East and Africa
    • 9.3.1 Nigeria
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Ethiopia
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 Iran
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Algeria
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Others
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
  • 9.4 Europe
    • 9.4.1 Turkey
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Georgia
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Armenia
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porter's Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Paramount Agrovet Pvt. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biogenesis Bago
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Brilliant Bio Pharma Private Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 China Animal Husbandry Group
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 FGBI "Federal Center for Animal Health"
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Indian Immunologicals Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Limor de Colombia
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Merck & Co. Inc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Vecol S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Vetal Animal Health Products Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Foot and Mouth Disease (FMD) Vaccine Market: Major Drivers and Challenges
  • Figure 2: Global: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Animal Type (in %), 2022
  • Figure 4: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Vaccine Type (in %), 2022
  • Figure 5: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 8: Global: Foot and Mouth Disease (FMD) Vaccine (Cattle) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Foot and Mouth Disease (FMD) Vaccine (Cattle) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Foot and Mouth Disease (FMD) Vaccine (Pig) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Foot and Mouth Disease (FMD) Vaccine (Pig) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Foot and Mouth Disease (FMD) Vaccine (Sheep and Goat) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Foot and Mouth Disease (FMD) Vaccine (Sheep and Goat) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Foot and Mouth Disease (FMD) Vaccine (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Foot and Mouth Disease (FMD) Vaccine (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Foot and Mouth Disease (FMD) Vaccine (Conventional Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Foot and Mouth Disease (FMD) Vaccine (Oil-Based Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Foot and Mouth Disease (FMD) Vaccine (Oil-Based Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Foot and Mouth Disease (FMD) Vaccine (Aluminum hydroxide/saponin-based Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Foot and Mouth Disease (FMD) Vaccine (Aluminum hydroxide/saponin-based Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Foot and Mouth Disease (FMD) Vaccine (Conventional Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Foot and Mouth Disease (FMD) Vaccine (Emergency Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Foot and Mouth Disease (FMD) Vaccine (Emergency Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Foot and Mouth Disease (FMD) Vaccine (Government Organizations) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Foot and Mouth Disease (FMD) Vaccine (Government Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Foot and Mouth Disease (FMD) Vaccine (Distributors/Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Foot and Mouth Disease (FMD) Vaccine (Distributors/Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Foot and Mouth Disease (FMD) Vaccine (Private Vet) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Foot and Mouth Disease (FMD) Vaccine (Private Vet) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Foot and Mouth Disease (FMD) Vaccine (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Foot and Mouth Disease (FMD) Vaccine (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: China: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: India: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: India: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Bangladesh: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Bangladesh: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Vietnam: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Vietnam: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Korea: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Korea: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Others: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Others: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Latin America: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Brazil: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Brazil: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Argentina: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Argentina: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Others: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Others: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Latin America: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Nigeria: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Nigeria: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Ethiopia: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Ethiopia: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Iran: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Iran: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Algeria: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Algeria: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Europe: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Turkey: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Turkey: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Georgia: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Georgia: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Armenia: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Armenia: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Europe: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Global: Foot and Mouth Disease (FMD) Vaccine Industry: SWOT Analysis
  • Figure 75: Global: Foot and Mouth Disease (FMD) Vaccine Industry: Value Chain Analysis
  • Figure 76: Global: Foot and Mouth Disease (FMD) Vaccine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Foot and Mouth Disease (FMD) Vaccine Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Animal Type (in Million US$), 2023-2028
  • Table 3: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
  • Table 4: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Foot and Mouth Disease (FMD) Vaccine Market: Competitive Structure
  • Table 7: Global: Foot and Mouth Disease (FMD) Vaccine Market: Key Players